Literature DB >> 22825455

The gut microbiota, environment and diseases of modern society.

Judith R Kelsen1, Gary D Wu.   

Abstract

The human gut microbiota is a complex community that provides important metabolic functions to the host. Consequently, alterations in the gut microbiota have been associated with the pathogenesis of several human diseases associated with a disturbance in metabolism, particularly those that have been increasing in incidence over the last several decades including obesity, diabetes and atherosclerosis. In this review, we explore how advances in deep DNA sequencing technology have provided us a greater understanding of the factors that influence that composition of the gut microbiota and its possible links to the pathogenesis of these diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22825455      PMCID: PMC3463495          DOI: 10.4161/gmic.21333

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  83 in total

1.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

Review 2.  The adipocyte as an active participant in energy balance and metabolism.

Authors:  Michael K Badman; Jeffrey S Flier
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

3.  Metabolic endotoxemia initiates obesity and insulin resistance.

Authors:  Patrice D Cani; Jacques Amar; Miguel Angel Iglesias; Marjorie Poggi; Claude Knauf; Delphine Bastelica; Audrey M Neyrinck; Francesca Fava; Kieran M Tuohy; Chantal Chabo; Aurélie Waget; Evelyne Delmée; Béatrice Cousin; Thierry Sulpice; Bernard Chamontin; Jean Ferrières; Jean-François Tanti; Glenn R Gibson; Louis Casteilla; Nathalie M Delzenne; Marie Christine Alessi; Rémy Burcelin
Journal:  Diabetes       Date:  2007-04-24       Impact factor: 9.461

4.  Mode of delivery - effects on gut microbiota and humoral immunity.

Authors:  Anu Huurre; Marko Kalliomäki; Samuli Rautava; Minna Rinne; Seppo Salminen; Erika Isolauri
Journal:  Neonatology       Date:  2007-11-16       Impact factor: 4.035

5.  Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat.

Authors:  Jeremy E Davis; Nicholas K Gabler; Jennifer Walker-Daniels; Michael E Spurlock
Journal:  Obesity (Silver Spring)       Date:  2008-04-10       Impact factor: 5.002

6.  Human metabolic phenotype diversity and its association with diet and blood pressure.

Authors:  Elaine Holmes; Ruey Leng Loo; Jeremiah Stamler; Magda Bictash; Ivan K S Yap; Queenie Chan; Tim Ebbels; Maria De Iorio; Ian J Brown; Kirill A Veselkov; Martha L Daviglus; Hugo Kesteloot; Hirotsugu Ueshima; Liancheng Zhao; Jeremy K Nicholson; Paul Elliott
Journal:  Nature       Date:  2008-04-20       Impact factor: 49.962

7.  Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance.

Authors:  Daniela M L Tsukumo; Marco A Carvalho-Filho; José B C Carvalheira; Patrícia O Prada; Sandro M Hirabara; André A Schenka; Eliana P Araújo; José Vassallo; Rui Curi; Lício A Velloso; Mario J A Saad
Journal:  Diabetes       Date:  2007-05-22       Impact factor: 9.461

8.  Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.

Authors:  Patrice D Cani; Rodrigo Bibiloni; Claude Knauf; Aurélie Waget; Audrey M Neyrinck; Nathalie M Delzenne; Rémy Burcelin
Journal:  Diabetes       Date:  2008-02-27       Impact factor: 9.461

Review 9.  Species divergence and the measurement of microbial diversity.

Authors:  Catherine A Lozupone; Rob Knight
Journal:  FEMS Microbiol Rev       Date:  2008-04-22       Impact factor: 16.408

10.  Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities.

Authors:  Catherine A Lozupone; Micah Hamady; Scott T Kelley; Rob Knight
Journal:  Appl Environ Microbiol       Date:  2007-01-12       Impact factor: 4.792

View more
  19 in total

Review 1.  Dysbiosis and the immune system.

Authors:  Maayan Levy; Aleksandra A Kolodziejczyk; Christoph A Thaiss; Eran Elinav
Journal:  Nat Rev Immunol       Date:  2017-03-06       Impact factor: 53.106

2.  Lactobacillus acidophilus ATCC 4356 prevents atherosclerosis via inhibition of intestinal cholesterol absorption in apolipoprotein E-knockout mice.

Authors:  Ying Huang; Jinfeng Wang; Guihua Quan; Xiaojun Wang; Longfei Yang; Lili Zhong
Journal:  Appl Environ Microbiol       Date:  2014-09-26       Impact factor: 4.792

3.  Lipocalin 2 deficiency-induced gut microbiota dysbiosis evokes metabolic syndrome in aged mice.

Authors:  Vishal Singh; Sarah Galla; Rachel M Golonka; Andrew D Patterson; Benoit Chassaing; Bina Joe; Matam Vijay-Kumar
Journal:  Physiol Genomics       Date:  2020-07-06       Impact factor: 3.107

Review 4.  Mutualistic interplay between bacteriophages and bacteria in the human gut.

Authors:  Andrey N Shkoporov; Christopher J Turkington; Colin Hill
Journal:  Nat Rev Microbiol       Date:  2022-06-30       Impact factor: 60.633

5.  Special issue: gut microbial communities in health and disease.

Authors:  John F Rawls
Journal:  Gut Microbes       Date:  2012-06-12

6.  Glycan degradation (GlyDeR) analysis predicts mammalian gut microbiota abundance and host diet-specific adaptations.

Authors:  Omer Eilam; Raphy Zarecki; Matthew Oberhardt; Luke K Ursell; Martin Kupiec; Rob Knight; Uri Gophna; Eytan Ruppin
Journal:  mBio       Date:  2014-08-12       Impact factor: 7.867

7.  Translational medicine as a new clinical tool and application which improves metabolic diseases: perspectives from 2012 Sino-American symposium on clinical and translational medicine.

Authors:  Lin Shi; Elena López Villar; Chengshui Chen
Journal:  Clin Transl Med       Date:  2014-02-10

Review 8.  The central role of the gut microbiota in chronic inflammatory diseases.

Authors:  Caroline Marcantonio Ferreira; Angélica Thomaz Vieira; Marco Aurelio Ramirez Vinolo; Fernando A Oliveira; Rui Curi; Flaviano dos Santos Martins
Journal:  J Immunol Res       Date:  2014-09-18       Impact factor: 4.818

9.  Effect of short-term probiotic Enterococcus faecium SF68 dietary supplementation in overweight and obese cats without comorbidities.

Authors:  Aarti Kathrani; Jennifer A Larsen; Philip H Kass; Andrea J Fascetti
Journal:  Vet Rec Open       Date:  2016-04-06

Review 10.  Probiotics for prevention of necrotizing enterocolitis in preterm infants: systematic review and meta-analysis.

Authors:  Arianna Aceti; Davide Gori; Giovanni Barone; Maria Luisa Callegari; Antonio Di Mauro; Maria Pia Fantini; Flavia Indrio; Luca Maggio; Fabio Meneghin; Lorenzo Morelli; Gianvincenzo Zuccotti; Luigi Corvaglia
Journal:  Ital J Pediatr       Date:  2015-11-14       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.